These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36856310)

  • 1. Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis.
    Zhan Y; Zhang R; Li G
    Ren Fail; 2023 Dec; 45(1):2182603. PubMed ID: 36856310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Magnesium Supplementation on Chronic Kidney Disease-Mineral and Bone Disorder in Hemodialysis Patients: A Meta-Analysis of Randomized Controlled Trials.
    Guo G; Zhou J; Xu T; Sheng Z; Huang A; Sun L; Yao L
    J Ren Nutr; 2022 Jan; 32(1):102-111. PubMed ID: 34531112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review.
    Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sclerostin in vascular calcification in CKD: a meta-analysis.
    Lin Y; Mao L; Chen S; Zhou C
    Ren Fail; 2023 Dec; 45(1):2186151. PubMed ID: 36880646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium as a Calcification Inhibitor.
    Hénaut L; Massy ZA
    Adv Chronic Kidney Dis; 2018 May; 25(3):281-290. PubMed ID: 29793668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.
    Bressendorff I; Hansen D; Schou M; Kragelund C; Brandi L
    BMJ Open; 2017 Jun; 7(6):e016795. PubMed ID: 28645983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and clinical implications of vascular calcification of chronic kidney disease in Mexico].
    Bañuelos-Chávez KV; Cerrillos-Gutiérrez JI; Nario JC; Abundis-Jiménez J; Preciado-Rojas P; Campos-Mariz A; Cortés-Sanabria L; Cueto-Manzano AM; Rojas-Campos E
    Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S151-7. PubMed ID: 29697236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.
    Liu Y; Yang Q; Chen G; Zhou T
    Curr Pharm Des; 2022; 28(40):3289-3304. PubMed ID: 36305135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Ascorbic Acid on Mineral and Bone Disorders in Hemodialysis Patients: a Systematic Review and Meta-Analysis.
    Ke G; Huang J; Zhu Y; Yang J; Zhang Y; Chen L; Hu J; Tao S; Hu Y; Yang D; Liu S
    Kidney Blood Press Res; 2018; 43(5):1459-1471. PubMed ID: 30248670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease.
    Zelt JG; McCabe KM; Svajger B; Barron H; Laverty K; Holden RM; Adams MA
    J Pharmacol Exp Ther; 2015 Dec; 355(3):451-62. PubMed ID: 26487689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis.
    Fan Z; Wei X; Zhu X; Yang K; Tian L; Du Y; Yang L
    Sci Rep; 2024 Feb; 14(1):4477. PubMed ID: 38396063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis session: the perfect storm for vascular calcification.
    Seras M; Martín de Francisco ÁL; Piñera C; Gundin S; García-Unzueta M; Kislikova M; Albines Z; Serrano M; Arias M
    Nefrologia; 2015; 35(5):448-56. PubMed ID: 26306970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.
    Leenders NHJ; Bos C; Hoekstra T; Schurgers LJ; Vervloet MG; Hoenderop JGJ
    Nephrol Dial Transplant; 2022 May; 37(6):1049-1058. PubMed ID: 35134986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    Andrews ES; Perrenoud L; Nowak KL; You Z; Pasch A; Chonchol M; Kendrick J; Jalal D
    PLoS One; 2018; 13(10):e0205831. PubMed ID: 30356327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease.
    Vermeulen EA; Eelderink C; Hoekstra T; van Ballegooijen AJ; Raijmakers P; Beulens JW; de Borst MH; Vervloet MG
    Trials; 2022 Sep; 23(1):769. PubMed ID: 36096824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nitrogen-containing bisphosphonates and nitrogen-containing bisphosphonates for the treatment of atherosclerosis and vascular calcification: A meta-analysis.
    Xu W; Lu G; Gong L; Tang W; Liu X; Yang Q; Jiang W; Liu X; Li X
    Medicine (Baltimore); 2024 Jun; 103(23):e38404. PubMed ID: 38847712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of low and high dialysate calcium concentrations on cardiovascular disease and death in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis.
    Kamei K; Yamada S; Hashimoto K; Konta T; Hamano T; Fukagawa M
    Clin Exp Nephrol; 2024 Jun; 28(6):557-570. PubMed ID: 38396314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.